Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/2006
12/14/2006US20060281719 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
12/14/2006US20060281704 Regulation of endogenous gene expression in cells using zinc finger proteins
12/14/2006US20060280820 Use of an extract of Aloysia/Verbena/Lippia triphylla/citriodora for the treatment of chronic and/or inflammatory diseases
12/14/2006US20060280749 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor
12/14/2006CA2610881A1 Eye drop containing roflumilast
12/13/2006EP1731520A1 Pyrrolo[2,3-d]pyrimidine derivatives which are antagonists of adenosine A1, A2A, and A3
12/13/2006EP1731516A2 The 9,11-cycloendoperoxide prodrugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
12/13/2006EP1731134A1 Functional powders
12/13/2006EP1731131A1 Hgf production accelerator containing heparin-like oligosaccharide
12/13/2006EP1729785A1 Eye drops consisting of filtered clayey water for treating glaucoma
12/13/2006EP1729753A2 Use of an nmda receptor antagonist the treatment of tinnitus induced by cochlear excitotoxicity
12/13/2006EP1729748A1 Microemulsion preconcentrate comprising a renin inhibitor
12/13/2006EP1420788B1 Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders
12/13/2006EP1397132A4 Pirenzepine ophthalmic gel
12/13/2006EP1383765B1 Carboline derivatives as inhibitors of phosphodiesterase 5 (PDE5) for the treatment of cardiovascular diseases and erectile dysfunction
12/13/2006EP1268558B1 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
12/13/2006EP1261712B1 Proteins named fctrx and nucleic acids encoding same
12/13/2006EP1206554B1 Activatable recombinant neurotoxins
12/13/2006EP1148880B1 Methods for restoring and/or enhancing accommodation in pseudo phakia
12/13/2006CN1876683A Human antibodies that bind human TNFalpha
12/13/2006CN1876186A Endostatin conjugate and its preparation method
12/13/2006CN1876152A A medicine for treating nervous deafness and preparation process thereof
12/13/2006CN1876064A A protective agent for resisting UV-B radiation damage
12/13/2006CN1876033A Compound Chinese preparation with gingko, its preparation method and use
12/13/2006CN1875977A Use of tanshinone compound in preparation of medicine for treating Grave's disease
12/13/2006CN1289497C 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide
12/13/2006CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006CN1289095C Physiologically balanced ionized acidic solution and methodology for use in wound healing
12/13/2006CN1289086C Uses for anti-malarial therapeutic agents
12/13/2006CN1289084C Pharmaceutical formulation
12/13/2006CN1289073C Hair growth stimulant
12/13/2006CN1289072C Aniline derivatives or salts thereof and cytokine prodn inhibitors containing same
12/12/2006US7148331 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof
12/12/2006US7148245 Skin disorders; aging resistance of skins; antiinflammatory agents; antiallergens; rheumatic diseases; cardiovascular disorders
12/12/2006US7148214 Antihistaminic spiro compounds
12/12/2006US7147844 System for stabilizing lacrimal fluid layer
12/12/2006CA2451725C Therapeutic combinations for the treatment of hormone deficiencies
12/12/2006CA2347741C Thiazole-derivatives
12/12/2006CA2098176C Angiotensin ii receptor blocking compositions
12/07/2006WO2006129867A2 ENHANCED EXPRESSION OF LACTOFERRIN mRNA BY LACRITIN
12/07/2006WO2006129826A1 Novel piperidine derivative
12/07/2006WO2006129785A1 Concomitant pharmaceutical agents and use thereof
12/07/2006WO2006129784A1 INTERFERON-α REGULATOR
12/07/2006WO2006129679A1 Spiropiperidine compound and medicinal use thereof
12/07/2006WO2006129623A1 Thienotriazolodiazepine compound and a medicinal use thereof
12/07/2006WO2006129524A1 Carbonyl compound remover
12/07/2006WO2006101839A3 Enhanced bimatoprost ophthalmic solution
12/07/2006WO2006050045A3 Inhibitors of jun n-terminal kinases for treating glaucomatous retinopathy and ocular diseases
12/07/2006US20060276521 e.g. N-{4-[2-(4-{[amino(imino)methyl]amino}phenyl)ethyl]-1,3-thiazol-2-yl}acet-amide; vascular adhesion protein (semicarbazide sensitive amine oxidase) inhibitor; antidiabetic, hypotensive agent; non-insulin dependent diabetis obesity, retinopathy complications, atherosclerosis, macular edema
12/07/2006US20060276516 Inhibitors of kinases and treatment of diseases mediated by cytokines produced by p38
12/07/2006US20060276497 Novel multicyclic compounds and the use thereof
12/07/2006US20060276488 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis.
12/07/2006US20060276460 Use of piperazine phenothiazine derivatives in the manufacture of a medicament with neuroprotector and/or neurotrophic effects on cns and/or pns
12/07/2006US20060276427 Regulation of endogenous gene expression in cells using zinc finger proteins
12/07/2006US20060276392 Treatments employing neuronal exocytosis-inhibiting peptides
12/07/2006US20060276386 Use of substances inhibiting the association of said protein with ubiquitin c-terminal hydrolase for altering cellular responses to tgf-beta or bmp
12/07/2006US20060276384 Peptides and medicinal compositions containing the same
12/07/2006US20060275287 Scroll compressor
12/07/2006CA2610274A1 Benzofuran derivatives with therapeutic activities
12/07/2006CA2609388A1 Novel piperidine derivative
12/06/2006EP1728791A1 Composition for solid pharmaceutical preparation of solifenacin or salt thereof
12/06/2006EP1728504A1 Emulsion stabilizer
12/06/2006EP1727529A2 Prevention of retinopathy by inhibition of the visual cycle
12/06/2006EP1318977B1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
12/06/2006EP1313459B1 Polycyclic dianthraquinones as anti-cancer and anti-angiogenic agents
12/06/2006EP0837934B1 Human vascular endothelial growth factor 2
12/06/2006CN1874770A Therapeutic agent for keratoconjunctiva disorder
12/06/2006CN1872242A Injection preparation of leaf of nakedflower beautyberry, and preparation method
12/06/2006CN1872211A Medication products of containing euphrasy, and preparation method
12/06/2006CN1872109A Drop pills of acanthopanax root, and preparation method
12/06/2006CN1872105A Application of holly and extractive in preparing medication for anti virus
12/06/2006CN1872048A Drop pills of soybean aglycone, and preparation method
12/06/2006CN1872046A Drop pills of soybean aglycone, and preparation method
12/06/2006CN1872038A Drop pill type eye drip fluid of chloramphenicol, and preparation method
12/06/2006CN1288150C Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases
12/06/2006CN1288148C 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
12/06/2006CN1287806C Compound leech eye drip for treating cataract and method of preparation thereof
12/05/2006USRE39419 Estrogen agonist/antagonist metabolites
12/05/2006US7144918 Enzyme inhibitors; anticancer agents
12/05/2006US7144913 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
12/05/2006US7144873 Therapy for anticancer agents, blood disorders; dissolving in nonaqueous solvent
12/05/2006US7144870 Gene therapy; lyases; hyaluronidase; anticancer agents (retinoblastomas); kits
12/05/2006US7144707 Determination of risk and treatment of complications of prematurity
12/05/2006CA2396458C Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
12/05/2006CA2384929C A novel angiogenesis inhibitor
11/2006
11/30/2006WO2006128152A2 Method to treat and prevent posterior capsule opacification
11/30/2006WO2006127945A1 Compositions and methods of treating retinal disease
11/30/2006WO2006127121A2 Polysaccharide and polyol composition for treating dry eye and related methods of manufacture and methods of use
11/30/2006WO2006126581A1 Combination drug
11/30/2006WO2006107902A3 Use of spirostenols to treat mitochondrial disorders
11/30/2006US20060270740 Prostaglandin derivatives
11/30/2006US20060270721 EP4 receptor agonist, compositions and methods thereof
11/30/2006US20060270687 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states
11/30/2006US20060270681 Pyridazine derivatives
11/30/2006US20060270679 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/30/2006US20060270676 Hydrazono-malonitriles
11/30/2006US20060270665 Combination comprising an agent decreasing VEGF activity and an agent decreasing EGF activity
11/30/2006US20060270649 Azetidine derivatives, their preparation and medicaments containing them
11/30/2006US20060269632 Remedies for allergic diseases and process for producing the same
11/30/2006US20060269548 Lymphatic endothelial cells materials and methods